Sectors

Health care

17 companies

Filings

AccorCAC 40
FR0000120404· AC
172 filings07/08/2026
Cellectis
FR0010425595· ALCLS
102 filings06/08/2026
Societe Anonyme des Bains de Mer et du Cercle des Etrangers A Monaco
MC0000031187· BAIN
19 filings05/08/2026
SanofiCAC 40
FR0000120578· SAN
431 filings04/08/2026
Carbios
FR0011648716· ALCRB
48 filings03/08/2026
Ipsen SA
FR0010259150· IPN
204 filings03/08/2026
Novacyt
FR0010397232· ALNOV
52 filings03/08/2026
Emeis
FR001400NLM4· EMEIS
113 filings31/07/2026
DBV Technologies
FR0010417345· DBV
179 filings30/07/2026
Abivax
FR0012333284· ABVX
123 filings30/07/2026
Inventiva
FR0013233012· IVA
181 filings30/07/2026
EssilorluxotticaCAC 40
FR0000121667· EL
160 filings29/07/2026
Innate Pharma
FR0010331421· IPH
130 filings23/07/2026
Valneva SE
FR0004056851· VLA
160 filings22/07/2026
Ose Immunotherapeutics
FR0012127173· OSE
142 filings08/07/2026
Genfit
FR0004163111· GNFT
100 filings08/07/2026
Nicox SA
FR0013018124· COX
60 filings01/07/2026

Latest filings

→

07/08/2026
Disclosure of shares outstanding and voting rights - 07.08.2026
AccorVoting rights and capitalFR
06/08/2026
Cellectis Reports Financial Results for the Second Quarter 2026
CellectisHalf-year financial reportFR
05/08/2026
Monthly information on share capital and company voting rights
CellectisVoting rights and capitalFR
05/08/2026
BAINS DE MER MONACO : Modalités de mise à disposition des documents préparatoires aux Assemblées Générales du 18 septembre 2026
Societe Anonyme des Bains de Mer et du Cercle des Etrangers A MonacoAGM documentsFrench
05/08/2026
BAINS DE MER MONACO : Avis de réunion valant avis de convocation aux Assemblées Générales
Societe Anonyme des Bains de Mer et du Cercle des Etrangers A MonacoAGM documentsFrench
04/08/2026
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
SanofiInside informationFR
03/08/2026
Carbios provides an update on the financing of its Longlaville plant project
CarbiosInside informationFR
03/08/2026
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026
Ipsen SAShare buybackFR
03/08/2026
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
NovacytInside informationFrench
03/08/2026
Launch of a €225 million tranche of its share buyback programme
AccorShare buybackFR
31/07/2026
Premier semestre 2026 : Accor confirme son agilité dans un environnement mondial contrasté
AccorInside informationFrench
31/07/2026
Availability of the 2026 Interim Financial Report
AccorHalf-year financial reportFR
31/07/2026
Rapport Financier Semestriel 2026
EmeisHalf-year financial reportFrench
30/07/2026
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
DBV TechnologiesInside informationFR
30/07/2026
Cellectis to Report Second Quarter Financial Results on August 6, 2026
CellectisInside informationFR
30/07/2026
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
AbivaxInside informationFrench
30/07/2026
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
InventivaEarnings releaseFR
30/07/2026
Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report
EmeisHalf-year financial reportFR
30/07/2026
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
EmeisHalf-year financial reportFrench
30/07/2026
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
Ipsen SAHalf-year financial reportFR